Dose-dependent tumor regression during sirolimus therapy in an advanced juvenile nasopharyngeal angiofibroma case
Paediatrics
Dose-dependent tumor regression during sirolimus therapy in an advanced juvenile nasopharyngeal angiofibroma case
Paediatrics

Dose-dependent tumor regression during sirolimus therapy in an advanced juvenile nasopharyngeal angiofibroma case

Pediatr Int. 2024 Jan-Dec;66(1):e15807. doi: 10.1111/ped.15807.

NO ABSTRACT

PMID:39312387 | DOI:10.1111/ped.15807